ID   MMP2_RAT                Reviewed;         662 AA.
AC   P33436; P97581; Q6GMM9;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   24-JUL-2024, entry version 175.
DE   RecName: Full=72 kDa type IV collagenase;
DE            EC=3.4.24.24 {ECO:0000250|UniProtKB:P08253};
DE   AltName: Full=72 kDa gelatinase;
DE   AltName: Full=Gelatinase A;
DE   AltName: Full=Matrix metalloproteinase-2;
DE            Short=MMP-2;
DE   Contains:
DE     RecName: Full=PEX;
DE   Flags: Precursor;
GN   Name=Mmp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7916617; DOI=10.1042/bj2910441;
RA   Marti H.P., McNeil L., Davies M., Martin J., Lovett D.H.;
RT   "Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-
RT   messenger inducibility in glomerular mesangial cells.";
RL   Biochem. J. 291:441-446(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Skin;
RA   Okada A., Basset P.;
RT   "The cloning of the cDNA encoding rat gelatinase A from a rat skin wound
RT   cDNA library.";
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   CLEAVAGE OF SIGNAL PEPTIDE AFTER ALA-29, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=26479776; DOI=10.1021/acs.jproteome.5b00820;
RA   Tsuchiya T., Osaki T., Minamino N., Sasaki K.;
RT   "Peptidomics for studying limited proteolysis.";
RL   J. Proteome Res. 14:4921-4931(2015).
CC   -!- FUNCTION: Ubiquitinous metalloproteinase that is involved in diverse
CC       functions such as remodeling of the vasculature, angiogenesis, tissue
CC       repair, tumor invasion, inflammation, and atherosclerotic plaque
CC       rupture. As well as degrading extracellular matrix proteins, can also
CC       act on several nonmatrix proteins such as big endothelial 1 and beta-
CC       type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu
CC       bond. Appears to have a role in myocardial cell death pathways.
CC       Contributes to myocardial oxidative stress by regulating the activity
CC       of GSK3beta. Cleaves GSK3beta in vitro. Involved in the formation of
CC       the fibrovascular tissues (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: PEX, the C-terminal non-catalytic fragment of MMP2, possesses
CC       anti-angiogenic and anti-tumor properties and inhibits cell migration
CC       and cell adhesion to FGF2 and vitronectin. Ligand for integrin alpha-
CC       v/beta3 on the surface of blood vessels (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Cleavage of gelatin type I and collagen types IV, V, VII, X.
CC         Cleaves the collagen-like sequence Pro-Gln-Gly-|-Ile-Ala-Gly-Gln.;
CC         EC=3.4.24.24; Evidence={ECO:0000250|UniProtKB:P08253};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:P08253};
CC       Note=Binds 4 Ca(2+) ions per subunit. {ECO:0000250|UniProtKB:P08253};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P08253};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250|UniProtKB:P08253};
CC   -!- SUBUNIT: Interacts (via the C-terminal hemopexin-like domains-
CC       containing region) with the integrin alpha-V/beta-3; the interaction
CC       promotes vascular invasion in angiogenic vessels and melamoma cells.
CC       Interacts (via the C-terminal PEX domain) with TIMP2 (via the C-
CC       terminal); the interaction inhibits the degradation activity. Interacts
CC       with GSK3B (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250}. Membrane {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Note=Colocalizes with integrin alphaV/beta3 at the membrane surface in
CC       angiogenic blood vessels and melanomas. Found in mitochondria, along
CC       microfibrils, and in nuclei of cardiomyocytes (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch motif
CC       binds the catalytic zinc ion, thus inhibiting the enzyme. The
CC       dissociation of the cysteine from the zinc ion upon the activation-
CC       peptide release activates the enzyme.
CC   -!- PTM: Phosphorylation on multiple sites modulates enzymatic activity.
CC       Phosphorylated by PKC in vitro (By similarity). {ECO:0000250}.
CC   -!- PTM: The propeptide is processed by MMP14 (MT-MMP1) and MMP16 (MT-MMP3)
CC       (By similarity). Autocatalytic cleavage in the C-terminal produces the
CC       anti-angiogenic peptide, PEX. This processing appears to be facilitated
CC       by binding integrin integrinv/beta3 (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase M10A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X71466; CAA50583.1; -; mRNA.
DR   EMBL; U65656; AAB41692.1; -; mRNA.
DR   EMBL; BC074013; AAH74013.1; -; mRNA.
DR   PIR; S34780; S34780.
DR   RefSeq; NP_112316.2; NM_031054.2.
DR   AlphaFoldDB; P33436; -.
DR   SMR; P33436; -.
DR   CORUM; P33436; -.
DR   STRING; 10116.ENSRNOP00000022679; -.
DR   BindingDB; P33436; -.
DR   ChEMBL; CHEMBL1075175; -.
DR   MEROPS; M10.003; -.
DR   GlyCosmos; P33436; 2 sites, No reported glycans.
DR   GlyGen; P33436; 2 sites.
DR   PhosphoSitePlus; P33436; -.
DR   PaxDb; 10116-ENSRNOP00000022679; -.
DR   Ensembl; ENSRNOT00000022679.7; ENSRNOP00000022679.7; ENSRNOG00000016695.7.
DR   Ensembl; ENSRNOT00055033172; ENSRNOP00055026889; ENSRNOG00055019436.
DR   Ensembl; ENSRNOT00060029131; ENSRNOP00060023454; ENSRNOG00060017036.
DR   Ensembl; ENSRNOT00065024330; ENSRNOP00065019002; ENSRNOG00065014715.
DR   GeneID; 81686; -.
DR   KEGG; rno:81686; -.
DR   AGR; RGD:621316; -.
DR   CTD; 4313; -.
DR   RGD; 621316; Mmp2.
DR   eggNOG; KOG1565; Eukaryota.
DR   GeneTree; ENSGT00940000158511; -.
DR   InParanoid; P33436; -.
DR   OMA; CPKDSCN; -.
DR   OrthoDB; 5340816at2759; -.
DR   PhylomeDB; P33436; -.
DR   BRENDA; 3.4.24.24; 5301.
DR   Reactome; R-RNO-1442490; Collagen degradation.
DR   Reactome; R-RNO-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-RNO-1592389; Activation of Matrix Metalloproteinases.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   PRO; PR:P33436; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   GO; GO:0031012; C:extracellular matrix; IEA:InterPro.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0030017; C:sarcomere; ISO:RGD.
DR   GO; GO:0004175; F:endopeptidase activity; ISO:RGD.
DR   GO; GO:0001968; F:fibronectin binding; IPI:RGD.
DR   GO; GO:0004222; F:metalloendopeptidase activity; ISO:RGD.
DR   GO; GO:0008237; F:metallopeptidase activity; ISO:RGD.
DR   GO; GO:0008233; F:peptidase activity; IDA:RGD.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0001525; P:angiogenesis; IEP:RGD.
DR   GO; GO:0001955; P:blood vessel maturation; ISO:RGD.
DR   GO; GO:0060346; P:bone trabecula formation; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; IMP:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISO:RGD.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IEP:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IMP:RGD.
DR   GO; GO:0071498; P:cellular response to fluid shear stress; IEP:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; ISO:RGD.
DR   GO; GO:0071492; P:cellular response to UV-A; ISS:UniProtKB.
DR   GO; GO:0030574; P:collagen catabolic process; IDA:RGD.
DR   GO; GO:0007566; P:embryo implantation; ISO:RGD.
DR   GO; GO:0035987; P:endodermal cell differentiation; ISO:RGD.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0060325; P:face morphogenesis; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0007507; P:heart development; IDA:RGD.
DR   GO; GO:0001957; P:intramembranous ossification; ISO:RGD.
DR   GO; GO:0001553; P:luteinization; IEP:RGD.
DR   GO; GO:0048246; P:macrophage chemotaxis; IDA:RGD.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IDA:RGD.
DR   GO; GO:0045906; P:negative regulation of vasoconstriction; IDA:RGD.
DR   GO; GO:0001541; P:ovarian follicle development; IDA:RGD.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; IEP:RGD.
DR   GO; GO:0007567; P:parturition; IEP:RGD.
DR   GO; GO:0014012; P:peripheral nervous system axon regeneration; IDA:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:1903378; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; IMP:RGD.
DR   GO; GO:0030163; P:protein catabolic process; IDA:RGD.
DR   GO; GO:0006508; P:proteolysis; IDA:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:1904645; P:response to amyloid-beta; ISO:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IDA:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:RGD.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IDA:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IDA:RGD.
DR   GO; GO:0032526; P:response to retinoic acid; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0048705; P:skeletal system morphogenesis; ISO:RGD.
DR   GO; GO:0048771; P:tissue remodeling; IDA:RGD.
DR   CDD; cd00062; FN2; 3.
DR   CDD; cd00094; HX; 1.
DR   CDD; cd04278; ZnMc_MMP; 1.
DR   Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 2.
DR   Gene3D; 2.10.10.10; Fibronectin, type II, collagen-binding; 2.
DR   Gene3D; 2.110.10.10; Hemopexin-like domain; 1.
DR   InterPro; IPR000562; FN_type2_dom.
DR   InterPro; IPR036943; FN_type2_sf.
DR   InterPro; IPR000585; Hemopexin-like_dom.
DR   InterPro; IPR036375; Hemopexin-like_dom_sf.
DR   InterPro; IPR018487; Hemopexin-like_repeat.
DR   InterPro; IPR018486; Hemopexin_CS.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR033739; M10A_MMP.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001818; Pept_M10_metallopeptidase.
DR   InterPro; IPR021190; Pept_M10A.
DR   InterPro; IPR021158; Pept_M10A_Zn_BS.
DR   InterPro; IPR006026; Peptidase_Metallo.
DR   InterPro; IPR036365; PGBD-like_sf.
DR   PANTHER; PTHR10201:SF29; 72 KDA TYPE IV COLLAGENASE; 1.
DR   PANTHER; PTHR10201; MATRIX METALLOPROTEINASE; 1.
DR   Pfam; PF00040; fn2; 3.
DR   Pfam; PF00045; Hemopexin; 4.
DR   Pfam; PF00413; Peptidase_M10; 2.
DR   PIRSF; PIRSF001191; Peptidase_M10A_matrix; 1.
DR   PRINTS; PR00013; FNTYPEII.
DR   PRINTS; PR00138; MATRIXIN.
DR   SMART; SM00059; FN2; 3.
DR   SMART; SM00120; HX; 4.
DR   SMART; SM00235; ZnMc; 1.
DR   SUPFAM; SSF50923; Hemopexin-like domain; 1.
DR   SUPFAM; SSF57440; Kringle-like; 3.
DR   SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1.
DR   SUPFAM; SSF47090; PGBD-like; 1.
DR   PROSITE; PS00546; CYSTEINE_SWITCH; 1.
DR   PROSITE; PS00023; FN2_1; 3.
DR   PROSITE; PS51092; FN2_2; 3.
DR   PROSITE; PS00024; HEMOPEXIN; 1.
DR   PROSITE; PS51642; HEMOPEXIN_2; 4.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Angiogenesis; Autocatalytic cleavage; Calcium; Collagen degradation;
KW   Disulfide bond; Extracellular matrix; Glycoprotein; Hydrolase; Membrane;
KW   Metal-binding; Metalloprotease; Nucleus; Phosphoprotein; Protease;
KW   Reference proteome; Repeat; Secreted; Signal; Zinc; Zymogen.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000269|PubMed:26479776"
FT   PROPEP          30..109
FT                   /note="Activation peptide"
FT                   /id="PRO_0000028720"
FT   CHAIN           110..662
FT                   /note="72 kDa type IV collagenase"
FT                   /id="PRO_0000028721"
FT   CHAIN           445..662
FT                   /note="PEX"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000391629"
FT   DOMAIN          228..276
FT                   /note="Fibronectin type-II 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DOMAIN          286..334
FT                   /note="Fibronectin type-II 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DOMAIN          344..392
FT                   /note="Fibronectin type-II 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   REPEAT          474..518
FT                   /note="Hemopexin 1"
FT   REPEAT          519..565
FT                   /note="Hemopexin 2"
FT   REPEAT          567..615
FT                   /note="Hemopexin 3"
FT   REPEAT          616..662
FT                   /note="Hemopexin 4"
FT   REGION          110..221
FT                   /note="Collagenase-like 1"
FT   REGION          222..396
FT                   /note="Collagen-binding"
FT   REGION          397..467
FT                   /note="Collagenase-like 2"
FT   REGION          414..662
FT                   /note="Required for inhibitor TIMP2 binding"
FT                   /evidence="ECO:0000250"
FT   MOTIF           100..107
FT                   /note="Cysteine switch"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        404
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         102
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /note="in inhibited form"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         134
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         168
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         178
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         180
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         185
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         186
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         193
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         200
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         202
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         204
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         206
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         208
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         209
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         211
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         211
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         403
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         407
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         413
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         478
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         523
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         571
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   BINDING         620
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P08253"
FT   CARBOHYD        575
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        644
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        233..259
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DISULFID        247..274
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DISULFID        291..317
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DISULFID        305..332
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DISULFID        349..375
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DISULFID        363..390
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DISULFID        471..662
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   CONFLICT        42
FT                   /note="S -> A (in Ref. 1; CAA50583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        286
FT                   /note="G -> A (in Ref. 1; CAA50583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        369
FT                   /note="S -> N (in Ref. 1; CAA50583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        435
FT                   /note="N -> H (in Ref. 1; CAA50583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        586
FT                   /note="S -> A (in Ref. 1; CAA50583)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   662 AA;  74149 MW;  C56BD787473FC03E CRC64;
     MEARLVWGVL VGPLRVLCVL CCLLGHAIAA PSPIIKFPGD VSPKTDKELA VQYLNTFYGC
     PKESCNLFVL KDTLKKMQKF FGLPQTGDLD QNTIETMRKP RCGNPDVANY NFFPRKPKWD
     KNQITYRIIG YTPDLDPETV DDAFARALKV WSDVTPLRFS RIHDGEADIM INFGRWEHGD
     GYPFDGKDGL LAHAFAPGTG VGGDSHFDDD ELWTLGEGQV VRVKYGNADG EYCKFPFLFN
     GREYSSCTDT GRSDGFLWCS TTYNFEKDGK YGFCPHEALF TMGGNGDGQP CKFPFRFQGT
     SYNSCTTEGR TDGYRWCGTT EDYDRDKKYG FCPETAMSTV GGNSEGAPCV FPFTFLGNKY
     ESCTSAGRSD GKVWCATTTN YDDDRKWGFC PDQGYSLFLV AAHEFGHAMG LEHSQDPGAL
     MAPIYTYTKN FRLSNDDIKG IQELYGPSPD ADTDTGTGPT PTLGPVTPEI CKQDIVFDGI
     AQIRGEIFFF KDRFIWRTVT PRDKPTGPLL VATFWPELPE KIDAVYEAPQ EEKAVFFAGN
     EYWVYSASTL ERGYPKPLTS LGLPPDVQQV DAAFNWSKNK KTYIFSGDKF WRYNEVKKKM
     DPGFPKLIAD SWNAIPDNLD AVVDLQGGGH SYFFKGAYYL KLENQSLKSV KFGSIKSDWL
     GC
//
